<DOC>
	<DOC>NCT01058889</DOC>
	<brief_summary>The purpose of the study is to show if telemonitoring and automated feedback regarding glucose management, physical activity, blood pressure, and body weight improves treatment of patients with insulin dependent Type 2 Diabetes mellitus.</brief_summary>
	<brief_title>Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>In this clinical trial 50 patients with insulin dependent type 2 diabetes will be randomised in two study arms: monitoring of blood glucose and blood pressure using a telemedical device or in an arm with treatment as usual. Patients will the following measurement devices: blood glucose, blood pressure. Both devices can communicate with a mobile phone, which will also be provided to the patients. The mobile phone will transfer the data to a central, safe server. Patients will receive automated reminder/feedback. Caregivers can evaluate the transferred data whenever necessary via a web-based access. Data will be presented in tables as well as trend figures.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>Diabetes mellitus Type 2, age 1870 years, able to use a mobile phone Pacemaker, intracardial defibrillator, no cure planned within the active study period.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Diabetes mellitus Type 2</keyword>
	<keyword>Telemedicine</keyword>
	<keyword>Insulin</keyword>
</DOC>